SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Edvinsson L, MacKenzie ET, McCulloch J, Uddmann R. In: Olesen J, Edvinsson L, eds. Basic Mechanisms of Headache. Amsterdam: Elsevier; 1988:129-144.
  • 2
    Peters GA. Migraine: diagnosis and treatment with emphasis on the migraine-tension headache, provocative tests and use of rectal suppositories. Proc Staff Meet Mayo Clin. 1953;28:673-686.
  • 3
    Sicuteri F, Del Bene E, Poggioni M & Bonazzi A. Unmasking latent dysnociception in healthy subjects. Headache. 1987;27:180-185.
  • 4
    Hansen HJ & Drewes VM. The nitroglycerine ointment test—a double-blind examination. Dan Med Bull. 1970;17:226-229.
  • 5
    Schumacher GA & Wolff HG. Experimental studies on headache: contrast of histamine headache with headache of migraine and that associated with hypertension. Arch Neurol Psychiatry. 1941;45:199-214.
  • 6
    Lauritzen M. Pathophysiology of the migraine aura. The spreading depression theory. Brain. 1994;117 (pt 1):199-210.
  • 7
    Olesen J, Tfelt-Hansen P, Henriksen L & Larsen B. The common migraine attack may not be initiated by cerebral ischaemia. Lancet. 1981;2:438-440.
  • 8
    Olesen J. Cerebral blood flow in migraine with aura. Pathol Biol. 1992;40:318-324.
  • 9
    Wahl M, Schilling L, Parsons AA & Kaumann A. Involvement of calcitonin gene-related peptide (CGRP) and nitric oxide (NO) in the pial artery dilatation elicited by cortical spreading depression. Brain Res. 1994;637:204-210.
  • 10
    Colonna DM, Meng W, Deal DD, Gowda M & Busija DW. Neuronal NO promotes cerebral cortical hyperemia during cortical spreading depression in rabbits. Am J Physiol. 1997;272(pt 2):H1315-H1322.
  • 11
    Read SJ, Smith MI, Hunter AJ & Parsons AA. Enhanced nitric oxide release during cortical spreading depression following infusion of glyceryl trinitrate in the anesthetized cat. Cephalalgia. 1997;17:159-165.
  • 12
    Lauritzen M & Hansen AJ. The effect of glutamate receptor blockade on anoxic depolarization and cortical spreading depression. J Cereb Blood Flow Metab. 1992;12:223-229.
  • 13
    Obrenovitch TP & Zilkha E. Inhibition of cortical spreading depression by L-701,324, a novel antagonist at the glycine site of the N-methyl-d-aspartate receptor complex. Br J Pharmacol. 1996;117:931-937.
  • 14
    East SJ & Garthwaite J. NMDA receptor activation in rat hippocampus induces cyclic GMP formation through the L-arginine-nitric oxide pathway. Neurosci Lett. 1991;123:17-19.
  • 15
    Gault LM, Lin CW, LaManna JC & Lust WD. Changes in energy metabolites, cGMP and intracellular pH during cortical spreading depression. Brain Res. 1994;641:176-180.
  • 16
    Nei K, Matsuyama S, Shuntoh H & Tanaka C. NMDA receptor activation induces glutamate release through nitric oxide synthesis in guinea pig dentate gyrus. Brain Res. 1996;728:105-110.DOI: 10.1016/s0006-8993(96)00394-0
  • 17
    Myers DE. Potential neurogenic and vascular roles of nitric oxide in migraine headache and aura. Headache. 1999;39:118-124.
  • 18
    Thomsen LL & Olesen J. Nitric oxide theory of migraine. Clin Neurosci. 1998;5:28-33.
  • 19
    Christiansen I, Thomsen LL, Daugaard D, Ulrich V & Olesen J. Glyceryl trinitrate induces attacks of migraine without aura in sufferers of migraine with aura. Cephalalgia. 1999;19:660-667.
  • 20
    Thomsen LL, Kruuse C, Iversen HK & Olesen J. A nitric oxide donor (nitroglycerin) triggers genuine migraine attacks. Eur J Neurol. 1994;1:73-80.
  • 21
    Woods RP, Iacoboni M & Mazziotta JC. Bilateral spreading cerebral hypoperfusion during spontaneous migraine headache. N Engl J Med. 1994;331:1689-1692.